Sanofi is hoping its delayed program to switch Cialis in the US can learn lessons from the upcoming OTC launch of the erectile dysfunction treatment in the UK.
Sanofi Hopes UK Cialis Launch Will Illustrate US Switch Potential
Sanofi's upcoming launch of OTC Cialis in the UK “is quite important for getting a sense of what the over-the-counter opportunity could be and the appetite [in the US],” according to company CEO Paul Hudson.